Article
mTOR Signalling Pathway: A Potential Therapeutic Target for Ocular Neurodegenerative Diseases
29 Jun 2022
Abstract excerpt
Recent advances in the research of the mammalian target of the rapamycin (mTOR) signalling pathway demonstrated that mTOR is a robust therapeutic target for ocular degenerative diseases, including age-related macular degeneration (AMD), diabetic retinopathy (DR), and glaucoma. Although the exact mechanisms of individual ocular degenerative diseases are unclear, they share several common pathological processes,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
